Last reviewed · How we verify
impact on VASP test — Competitive Intelligence Brief
phase 3
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
impact on VASP test (impact on VASP test) — University Hospital, Brest. This drug impacts the VASP test by affecting platelet function.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| impact on VASP test TARGET | impact on VASP test | University Hospital, Brest | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- impact on VASP test CI watch — RSS
- impact on VASP test CI watch — Atom
- impact on VASP test CI watch — JSON
- impact on VASP test alone — RSS
Cite this brief
Drug Landscape (2026). impact on VASP test — Competitive Intelligence Brief. https://druglandscape.com/ci/impact-on-vasp-test. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing